IFNA1 and in situ carcinoma: To clarify whether non–DNA-damaging drugs like paclitaxel and DTX have similar effects as DNA damaging drugs on IFN responses, we used GSEA to compare expression of IFN-responsive genes in GC cell lines with and without CIS, ETP, 5FU, or DTX treatment.